Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07789899
Recruiting
A Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Two GSK3862995B Formulations in Healthy Participants
Phase 1 · United Kingdom · 1 site
Registry update: 1 Sept 2026
NCT07753226
Recruiting
A Study of SI-B036 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors
Phase 1 · China · 1 site
Registry update: 10 Sept 2026
NCT07746817
Recruiting
A Study of BYN-001 in Healthy Adults and in Adults With Moderate to Severe Atopic Dermatitis
Phase 1 · Australia · 1 site
Registry update: 30 Sept 2026
NCT07784959
Recruiting
Study of NXP900 With Lorlatinib in ALK+ Lung Cancer
Phase 1 · United States · 1 site
Registry update: 25 Aug 2026
NCT07776613
Recruiting
A Study of Romosozumab in People With Breast Cancer and Osteoporosis
Phase 2 · United States · 7 sites
Registry update: 20 Aug 2026
NCT07375199
Recruiting
Reducing Mental Health Stigmatization Among Healthcare Workers and Students Using a Virtual Reality Protocol: The VIRTUS Protocol
Not applicable · France · 2 sites
Registry update: 22 Oct 2026
NCT07765888
Recruiting
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
Phase 3 · Japan, United States · 21 sites
Registry update: 15 Oct 2026
NCT07631598
Recruiting
Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
Not applicable · United States · 8 sites
Registry update: 1 Oct 2026
NCT04903795
Recruiting
BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma
Phase 1 · United States · 1 site
Registry update: 18 Aug 2026
NCT07636811
Recruiting
A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)
Phase 2 · Germany, Spain, Ireland, Italy, Netherlands, United States · 16 sites
Registry update: 13 Oct 2026
NCT07769008
Recruiting
CCTA-Based vs CAG-Based CABG: A Multicenter Pragmatic Non-Inferiority Trial
Not applicable · China · 1 site
Registry update: 27 Oct 2026
NCT05314998
Recruiting
A study to evaluate the efficacy of oxaliplatin- or gemcitabine-based chemotherapy after allocation by standard criteria or by genetic markers in patients with resected pancreatic carcinoma
Phase 3 · Germany, Portugal, Sweden · 40 sites
Registry update: 21 Oct 2026
NCT07550517
Recruiting
PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT
Phase 2 · United States · 1 site
Registry update: 22 Sept 2026
2026-525478-21-00
Recruiting
A randomized, multiple ascending doses, clinical trial to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of CV-01 after double-blind, placebo-controlled multiple oral administrations for 2 weeks in healthy volunteers, and multiple oral administrations open-label for 2 weeks in a cohort of participants with drug resistant epilepsy
Phase 1 · Sweden · 2 sites
Registry update: 8 Jun 2026
NCT07754084
Recruiting
Comprehensive Clinical Prediction Rule for Acute Heart Failure
Not applicable · Hong Kong · 3 sites
Registry update: 5 Nov 2026
NCT07505186
Recruiting
Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma
Phase 2 · China · 1 site
Registry update: 2 Oct 2026
NCT07885618
Recruiting
Factors Influencing Outcomes in ECMO and Impella Patients: Metabolic and Thyroid Hormone Dynamics
Not applicable · Hungary · 1 site
Registry update: 21 Oct 2026
NCT07769502
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers
Phase 2 · Israel, Japan, Taiwan, United States · 7 sites
Registry update: 13 Oct 2026
NCT07576647
Recruiting
Optimized Recruitment to Drive Equitable Research in Stroke, Empowering Decision-making (ORDERed)
Not applicable · Canada · 3 sites
Registry update: 9 Oct 2026
NCT06996652
Recruiting
An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
Phase 2 · Canada, United States · 18 sites
Registry update: 30 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.